|
Volumn 22, Issue 8, 2015, Pages 981-982
|
New Griselimycins for Treatment of Tuberculosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GRISELIMYCIN;
NATURAL PRODUCT;
UNCLASSIFIED DRUG;
BACTERIAL PROTEIN;
CYCLOPEPTIDE;
TUBERCULOSTATIC AGENT;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BACTERIAL GROWTH;
BACTERICIDAL ACTIVITY;
CRYSTAL STRUCTURE;
DISSOCIATION CONSTANT;
DRUG STRUCTURE;
HUMAN;
LIPOPHILICITY;
METABOLIC STABILITY;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PRIORITY JOURNAL;
PROKARYOTE;
STREPTOMYCES;
SURFACE PLASMON RESONANCE;
TUBERCULOSIS;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
DRUG EFFECTS;
MOLECULARLY TARGETED THERAPY;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
MYCOBACTERIUM TUBERCULOSIS;
ANIMALS;
ANTITUBERCULAR AGENTS;
BACTERIAL PROTEINS;
HUMANS;
MOLECULAR TARGETED THERAPY;
MYCOBACTERIUM TUBERCULOSIS;
PEPTIDES, CYCLIC;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
|
EID: 84939623440
PISSN: 10745521
EISSN: None
Source Type: Journal
DOI: 10.1016/j.chembiol.2015.08.002 Document Type: Short Survey |
Times cited : (17)
|
References (9)
|